Ultime notizie per Rocket Lab (NASDAQ:RKLB) Azioni

ROCKET LAB USA INC

Rocket Lab USA

Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.

Jim Cramer

Tech

ACHR

ANET

CSCO

CSGP

RKLB

SEZL

VNOM

Da &#34;Mad Money&#34;, il confronto tra Arista e Cisco. Inoltre, le sue call su Archer, UTI, Sezzle, Rocket Lab, CoStar, Viper e Fiserv.

Jim Cramer dice no a questo titolo e ne consiglia uno più economico

Rocket,Lab,Building,Sign.,Auckland,,New,Zealand,-,February,8,

Equities

Large Cap

News

Movers

ARKX

Electron consegna un altro satellite per il cliente nipponico. L&#39;azienda annuncia anche una collaborazione con la NASA.

Rocket Lab: la terza missione per l&#39;iQPS del Giappone è un successo

Trump’s Economic Gambit Sparks Fierce Debate As Cathie Wood Sees A Reagan-Style Boom, Obama Adviser Calls Musk’s Role A ‘Performance Art’

ETFs

General

ARKK

ARKQ

Dall&#39;acquisizione di aziende innovative alla vendita strategica di asset: le decisioni che potrebbero ridefinire il futuro dei suoi fondi.

Le ultime mosse di Cathie Wood: operazioni che potrebbero guidare il mercato tech

Rocket Lab Corp

WIIM

GENK

GEN Restaurant Group shares are trading lower after the company reported mixed Q2 financial results.

Based on current business trends and conditions, the Company expects for full year 2025, the following:
<ul>
<li>Gross bookings in the range of $67.0 million to $74.0 million, reflecting a 2% to 13% increase from 2024.​</li>
<li>Revenue in the range of $64.0 million to $70.0 million, representing a 7% to 17% increase from 2024.</li>
<li>Non-GAAP gross margin in the range of 83% to 86%, which would compare to 86% in 2024.​</li>
<li>Non-GAAP operating income (loss) in the range of ($2.0 million)&nbsp;to $1.0 million, compared to $5.5 million income in 2024.​</li>
<li>Non-GAAP net income (loss) per diluted share in the range of ($0.07) to $0.03, compared to $0.25 income in 2024.​</li>
</ul>

Guidance

SVCO

Silvaco Group Affirms FY2025 Adj EPS Guidance of $(0.07)-$0.03 vs $(0.03) Est; Affirms FY2025 Sales Guidance of $64M-$70M vs $66.847M Est

NAGE

Niagen Bio shares are trading higher after reporting better-than-expected Q2 financial results.

Outset Medical shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance with its midpoint above estimates.

AMRZ

Amrize Sees FY2025 Sales $11.400B-$11.800B vs $11.890B Est

Manulife To Acquire Comvest Credit Partners For $937.5M

Management

NAKA

Nakamoto Holdings Names Amanda Fabiano as Chief Operating Officer

McEwen Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUX#NYSE">MUX</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 25 percent. This is a 123.08 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $46.700 million which missed the analyst consensus estimate of $51.271 million by 8.91 percent. This is a 1.63 percent decrease over sales of $47.476 million the same period last year.

Earnings

Earnings Misses

McEwen Mining Q2 EPS $0.06 Misses $0.08 Estimate, Sales $46.700M Miss $51.271M Estimate

Centerra Gold Inc. ("Centerra" or the "Company") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CG#TSX">CG</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGAU#NYSE">CGAU</a>) is pleased to announce that it has completed a technical study of its Goldfield project ("Goldfield" or "the Project") in Nevada, which confirms attractive economics for the Project, including an after-tax net present value (5%) ("NPV5%") of $245 million and an after-tax internal rate of return ("IRR") of 30%, using a long-term gold price of $2,500 per ounce and includes the impact of gold hedges on a portion of production in 2029 and 2030. Centerra is proceeding with the project and will immediately commence detailed engineering and early procurement activities for construction.
President and CEO, Paul Tomory, commented, "We are pleased to be advancing with development and construction at the Goldfield project. Over the last several months, Centerra has undertaken additional technical work and project optimizations that have significantly enhanced Goldfield's value proposition and have de-risked the project. Favourable gold prices combined with these recent developments have improved the Project's economics, enabling us to move forward with execution. We believe Goldfield is well positioned to deliver strong returns. The project is expected to be funded from Centerra's existing liquidity and is located in a top tier mining jurisdiction, with an approximate 7-year mine life, average annual gold production of around 100,000 ounces in peak production years at an all-in sustaining costNG ("AISC") of approximately $1,392 per ounce, and a competitive initial capital cost of about $250 million. First production from Goldfield is expected by the end of 2028, which would grow Centerra's near-term gold production profile, generate robust cash flow and deliver significant value to shareholders. We believe Goldfield to be ideally positioned in our project development pipeline, bringing gold production online as we continue to advance development of the longer-life Mount Milligan and Kemess gold-copper assets in British Columbia."
Goldfield Highlights
<ul>
<li>Attractive economics with low execution risk in a top tier mining jurisdiction. Goldfield is expected to yield an after-tax NPV5% of $245 million and after-tax IRR of 30%, using a long-term gold price of $2,500 per ounce, which includes the impact of gold hedges on a portion of production in 2029 and 2030 to lock in strong margins, safeguard project economics in the early years of the project, and expedite the capital payback period. The initial capital investment at Goldfield is $252 million, including approximately $40 million in pre-production stripping and other costs, and the Project is expected to benefit from a short timeline to first production by the end of 2028 and low execution risk given its relatively simple process flowsheet. The Project is located in a historic mining district of Nevada, one of the most reliable mining jurisdictions, offering a stable regulatory environment, skilled workforce, and strong support for resource development.</li>
<li>Supportive gold price environment has enhanced project returns. Since the start of 2025, the gold price has increased by 30%. As a result, long-term gold price estimates have increased to $2,500 per ounce, which is the gold price assumption for Goldfield's economics. In addition, Centerra has implemented a targeted gold hedging strategy on 50% of production in 2029 and 2030, with a gold price floor of $3,200 per ounce and an average gold price cap of $4,435 per ounce in 2029 and $4,705 per ounce in 2030, at no cost to the Company. This hedging strategy is expected to allow Centerra to lock in strong margins to safeguard project economics and support predictable cash flow during the ramp-up period, while maintaining exposure to rising gold prices for the life of mine ("LOM"). For the LOM, almost 80% of the planned production remains unhedged and fully exposed to market gold prices.</li>
<li>Additional technical work on crushing strategy optimization resulted in a positive impact on project economics. Over the last several months, Centerra advanced technical work to evaluate hybrid processing alternatives which led to an optimized process flowsheet. High-grade material is expected to be processed through a three-stage semi-portable crushing circuit to maximize recovery, and lower-grade material is expected to be processed as run-of-mine to maintain low capital intensity. The selective routing of mineralized material to the most economically appropriate path substantially improved average recoveries, from mid-60% to approximately 76%, and resulted in a positive impact to the overall project returns.</li>
<li>Goldfield is expected to grow Centerra's near-term gold production profile, making it a strategic asset as the Company continues to advance its longer-life gold-copper growth pipeline. The Project is expected to provide an increase in gold production, which will help offset natural declines at Öksüt, and ensure continuity as Centerra advances its next phase of long-life, gold-copper, cornerstone organic growth projects in British Columbia at Mount Milligan and Kemess.</li>
</ul>
Goldfield Project Summary
Goldfield is a conventional open-pit, heap leach project located in Nevada, a top tier mining jurisdiction. Centerra has completed a technical study which demonstrated a NPV5% of $245 million and IRR of 30%, using an assumed long-term gold price of $2,500 per ounce as well as gold hedges on a portion of production in 2029 and 2030. The technical study includes a mine life of approximately seven years, average annual gold production of 100,000 ounces for the peak production years between 2029 and 2032, at an AISCNG of $1,392 per ounce, and an initial capital cost of $252 million, which can be funded from Centerra's existing liquidity. First production is expected by the end of 2028, and will come from four open pits on the property, of which the Gemfield pit is approximately 80% of total LOM production. A summary of the production and cost profile is included in the table below.

CGAU

TSX:CG

Centerra Gold Announces It Completed Technical Study Of Its Goldfield Project In Nevada, Confirming After-Tax NPV Of $245M And An IRR Of 30%, Based On A $2,500 Per Ounce Gold Price And Including Gold Hedges For 2029-2030. Company Is Moving Forward With The Project, Starting Detailed Engineering And Early Procurement For Construction

E.L.F. Beauty shares are trading lower. The company reported Q1 financial results.

Amrize Q2 2025 EPS $0.78 Misses $1.15 Estimate, Sales $3.220B Miss $3.390B Estimate

IONQ

IonQ shares are trading lower after the company reported a Q2 EPS miss.

IGM Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IGM#TSX">IGM</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.99 by 8.08 percent. This is a 7 percent increase over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $898.700 million which missed the analyst consensus estimate of $909.375 million by 1.17 percent. This is a 10.09 percent increase over sales of $816.305 million the same period last year.

Earnings Beats

TSX:IGM

IGM Financial Q2 Adj. EPS $1.07 Beats $0.99 Estimate, Sales $898.700M Miss $909.375M Estimate

<ul>
<li>Proposed Transaction to Create Proprietary Digital Asset Management Platform with Established Institutional Leadership Team Poised to Capitalize on Digital Asset Growth</li>
<li>Establishes Defensible, Scalable Strategy in Underserved, Highly Attractive South Korean Market with First Mover Advantage in Bitcoin Treasury Strategies</li>
<li>Positions Parataxis Holdings to Launch Yield-Enhanced Bitcoin Treasury Strategy in U.S. and South Korean Markets</li>
<li>Transaction Would Provide Access of Up to $640 Million of Gross Proceeds Available to Support Acceleration of Digital Asset Purchases and Support Long-Term Strategy</li>
<li>Implies Pro Forma Equity Value of Up to $800 Million at $10.00 Per Share, Assuming No Redemptions and Issuance of Shares Under ELOC in Full</li>
</ul>

SBXD

Parataxis Holdings To Combine With SilverBox Corp IV; To List On NYSE Under "PRTX"

SOUTH SAN FRANCISCO, Calif and VANCOUVER, Canada, Aug. 6, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPIX#NASDAQ">EPIX</a>) today announced that, following the Company's receipt of an order from the Supreme Court of British Columbia (the "Court") on August 5, 2025, authorizing a reduction in the capital of the common shares of the Company (the "Common Shares" and the holders of such Common Shares, the "Shareholders") and concurrent distribution to the Shareholders, the board of directors of the Company (the "Board") has approved a return of capital distribution in the aggregate amount of US$80,000,000 (the "Distribution") to the Shareholders as part of the discontinuance and winding-up of the business of the Company.
The Distribution is scheduled to be paid on August 22, 2025, to Shareholders of record as of the close of business on August 19, 2025.
The Distribution will occur prior to the special meeting of the Company's Shareholders, optionholders and warrantholders that is being held to consider and approve the Company's previously announced transaction with XenoTherapeutics, Inc. ("Xeno"), a non-profit biotechnology company, under which Xeno will acquire all of the issued and outstanding Common Shares (the "Transaction"), which meeting is expected to be held on September 10, 2025 (the "Special Meeting"). On August 5, 2025, the Company obtained an interim order from the Court authorizing the Special Meeting.
In total, with the Distribution and the cash payable upon closing of the Transaction, each Shareholder is currently estimated to receive approximately US$1.91 per Common Share, exclusive of any contingent value rights payments Shareholders are entitled to receive pursuant to the Transaction.
About ESSA Pharma Inc.
ESSA is a pharmaceutical company that was previously focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4483211-1&amp;h=1953824285&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4377390-1%26h%3D1142875966%26u%3Dhttps%253A%252F%252Fwww.essapharma.com%252F%26a%3Dwww.essapharma.com&amp;a=www.essapharma.com.">www.essapharma.com.</a>

EPIX

ESSA Pharma To Distribute $80M To Shareholders

Buybacks

Kodiak Gas Services Board Approves $100M Increase To Share Repurchase Program

Groupon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(0.01) by 3671.43 percent. This is a 1350 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $125.702 million which beat the analyst consensus estimate of $122.456 million by 2.65 percent. This is a 0.87 percent increase over sales of $124.615 million the same period last year.

GRPN

Groupon Q2 Adj. EPS $0.25 Beats $(0.01) Estimate, Sales $125.702M Beat $122.456M Estimate

IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) sees Q3 sales of $25.000 million-$29.000 million vs $25.083 million analyst estimate.

IonQ Sees Q3 Sales $25.000M-$29.000M vs $25.083M Est

Doman Building Materials (TSX:<a class="ticker" href="https://www.benzinga.com/stock/DBM#TSX">DBM</a>) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.21 by 52.38 percent. This is a 60 percent increase over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $886.719 million which beat the analyst consensus estimate of $859.630 million by 3.15 percent. This is a 28.55 percent increase over sales of $689.800 million the same period last year.

TSX:DBM

Doman Building Materials Q2 Adj. EPS $0.32 Beats $0.21 Estimate, Sales $886.719M Beat $859.630M Estimate

Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) reported quarterly sales of $3.823 million which beat the analyst consensus estimate of $3.619 million by 5.64 percent. This is a 113.10 percent increase over sales of $1.794 million the same period last year.

GROY

Gold Royalty Q2 Sales $3.823M Beat $3.619M Estimate

Press Releases

Rocket Lab Executes Responsive Reschedule of Electron Manifest to Launch Next Mission in Two Days' Time

Rocket Lab to Launch Electron Mission for European Space Agency's Next-Generation Navigation System

Rocket Lab Successfully Launches 67th Electron Mission, Schedules Next Launch in Less Than 48 Hours

Rocket Lab Completes Record Launch Turnaround From Launch Complex 1, Successfully Deploys 68th Electron Mission

Rocket Lab Successfully Completes Critical Design Review for Space Development Agency's T2TL-Beta Constellation

Rocket Lab Selects Bollinger Shipyards to Support Modification of Neutron Landing Platform

Rocket Lab Announces Date of Second Quarter 2025 Financial Results

Rocket Lab Schedules Fifth Electron Mission for Constellation Operator iQPS

Mission Success for Rocket Lab's Latest Constellation Deployment Launch for iQPS

Opinion

How Artificial Intelligence is Disrupting Radar Systems Designed for Military Defense Ops

Comments

Rocket Lab

Notizie

Ultime notizie per Rocket Lab (NASDAQ:RKLB) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO